BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37011832)

  • 41. Regulating the stability and localization of CDK inhibitor p27(Kip1) via CSN6-COP1 axis.
    Choi HH; Guma S; Fang L; Phan L; Ivan C; Baggerly K; Sood A; Lee MH
    Cell Cycle; 2015; 14(14):2265-73. PubMed ID: 25945542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TSGΔ154-1054 splice variant increases TSG101 oncogenicity by inhibiting its E3-ligase-mediated proteasomal degradation.
    Chua HH; Huang CS; Weng PL; Yeh TH
    Oncotarget; 2016 Feb; 7(7):8240-52. PubMed ID: 26811492
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Auto-ubiquitination of Mdm2 enhances its substrate ubiquitin ligase activity.
    Ranaweera RS; Yang X
    J Biol Chem; 2013 Jun; 288(26):18939-46. PubMed ID: 23671280
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ATM activates p53 by regulating MDM2 oligomerization and E3 processivity.
    Cheng Q; Chen L; Li Z; Lane WS; Chen J
    EMBO J; 2009 Dec; 28(24):3857-67. PubMed ID: 19816404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.
    Wang X; Zha M; Zhao X; Jiang P; Du W; Tam AY; Mei Y; Wu M
    Nat Commun; 2013; 4():1551. PubMed ID: 23462994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Two distinct E3 ligases, SCF
    Liu J; Dong S; Wang H; Li L; Ye Q; Li Y; Miao J; Jhiang S; Zhao J; Zhao Y
    FASEB J; 2019 Sep; 33(9):10538-10550. PubMed ID: 31238008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The E3 ubiquitin ligase Itch regulates tumor suppressor protein RASSF5/NORE1 stability in an acetylation-dependent manner.
    Suryaraja R; Anitha M; Anbarasu K; Kumari G; Mahalingam S
    Cell Death Dis; 2013 Mar; 4(3):e565. PubMed ID: 23538446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The homeodomain transcription factor Hoxa2 interacts with and promotes the proteasomal degradation of the E3 ubiquitin protein ligase RCHY1.
    Bergiers I; Bridoux L; Nguyen N; Twizere JC; Rezsöhazy R
    PLoS One; 2013; 8(11):e80387. PubMed ID: 24244684
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of Mdm2-MdmX E3 ligase inhibitors using a cell-based ubiquitination assay.
    Herman AG; Hayano M; Poyurovsky MV; Shimada K; Skouta R; Prives C; Stockwell BR
    Cancer Discov; 2011 Sep; 1(4):312-25. PubMed ID: 22586610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CHIP-dependent p53 regulation occurs specifically during cellular senescence.
    Sisoula C; Trachana V; Patterson C; Gonos ES
    Free Radic Biol Med; 2011 Jan; 50(1):157-65. PubMed ID: 20974249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cooperative roles of c-Abl and Cdk5 in regulation of p53 in response to oxidative stress.
    Lee JH; Jeong MW; Kim W; Choi YH; Kim KT
    J Biol Chem; 2008 Jul; 283(28):19826-35. PubMed ID: 18490454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cul3-KLHL20 Ubiquitin Ligase Governs the Turnover of ULK1 and VPS34 Complexes to Control Autophagy Termination.
    Liu CC; Lin YC; Chen YH; Chen CM; Pang LY; Chen HA; Wu PR; Lin MY; Jiang ST; Tsai TF; Chen RH
    Mol Cell; 2016 Jan; 61(1):84-97. PubMed ID: 26687681
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis B virus X protein activates E3 ubiquitin ligase Siah-1 to control virus propagation via a negative feedback loop.
    Yeom S; Kim SS; Jeong H; Jang KL
    J Gen Virol; 2017 Jul; 98(7):1774-1784. PubMed ID: 28714848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of Pirh2 in mediating the regulation of p53 and c-Myc.
    Hakem A; Bohgaki M; Lemmers B; Tai E; Salmena L; Matysiak-Zablocki E; Jung YS; Karaskova J; Kaustov L; Duan S; Madore J; Boutros P; Sheng Y; Chesi M; Bergsagel PL; Perez-Ordonez B; Mes-Masson AM; Penn L; Squire J; Chen X; Jurisica I; Arrowsmith C; Sanchez O; Benchimol S; Hakem R
    PLoS Genet; 2011 Nov; 7(11):e1002360. PubMed ID: 22125490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long non-coding RNA p53 upregulated regulator of p53 levels (PURPL) promotes the development of gastric cancer.
    Cheng Z; Hong J; Tang N; Liu F; Gu S; Feng Z
    Bioengineered; 2022 Jan; 13(1):1359-1376. PubMed ID: 35012438
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The ubiquitin-protein ligase Itch regulates p73 stability.
    Rossi M; De Laurenzi V; Munarriz E; Green DR; Liu YC; Vousden KH; Cesareni G; Melino G
    EMBO J; 2005 Feb; 24(4):836-48. PubMed ID: 15678106
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aerobic glycolysis and tumor progression of hepatocellular carcinoma are mediated by ubiquitin of P53 K48-linked regulated by TRIM37.
    Ge Y; Zhao R; Li B; Xiao B; Zhou L; Zuo S
    Exp Cell Res; 2022 Dec; 421(2):113377. PubMed ID: 36252649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex.
    Gu J; Mao W; Ren W; Xu F; Zhu Q; Lu C; Lin Z; Zhang Z; Chu Y; Liu R; Ge D
    Cancer Lett; 2019 Feb; 443():125-134. PubMed ID: 30503554
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The anaphase-promoting complex/cyclosome is an E3 ubiquitin ligase for Mdm2.
    He Y; Tollini L; Kim TH; Itahana Y; Zhang Y
    Cell Cycle; 2014; 13(13):2101-9. PubMed ID: 24804778
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The p53-inducible E3 ubiquitin ligase p53RFP induces p53-dependent apoptosis.
    Huang J; Xu LG; Liu T; Zhai Z; Shu HB
    FEBS Lett; 2006 Feb; 580(3):940-7. PubMed ID: 16427630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.